| Literature DB >> 26126500 |
Xuanli Tang1, Bin Zhu2, Riping Chen3, Yunqin Hu4, Yinghua Zhang5, Xiaoling Zhu6, Hongyu Chen7, Yongjun Wang8.
Abstract
BACKGROUND: IgG4-TIN is the most common pattern of renal involvement in IgG4-related disease. There are several proposed diagnostic criteria of IgG4-TIN recently. Two of them proposed by the Mayo Clinic and JSN are predominant. However, histopathological criteria of the number of IgG4+ plasma cells and several histological features are still under discussion due to low amount of tissue in renal biopsy specimens and low frequency of this kind of specimens. We aimed to screen IgG4-TIN on archived renal biopsy samples and evaluated the application of two proposed diagnostic criteria.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26126500 PMCID: PMC4487857 DOI: 10.1186/s13000-015-0311-3
Source DB: PubMed Journal: Diagn Pathol ISSN: 1746-1596 Impact factor: 2.644
Two proposed criteria for IgG4-TIN by the Mayo Clinic and JSN
| Criterion | The Mayo Clinic criteria | JSN criteria |
|---|---|---|
| Histology | Plasma cell-rich TIN with >10 IgG4+ plasma cells/HPF field in the most concentrated field (mandatory criterion) | a. Dense lymphoplasmacytic infiltrate with >10 IgG4+ plasma cells/HPF and/or IgG4/IgG+ plasma cell ratio of >40 % |
| TBM immune complex deposits by immunofluorescence, immunohistochemistry, and/or electron microscopy | b. Characteristic storiform fibrosis | |
| Imaging | Small peripheral low-attenuation cortical nodules, round or wedge-shapped lesions, or diffuse patchy involvement | Multiple low-density lesions on enhanced CT, diffuse kidney enlargement, hypovascular solitary nodule, hypertrophic lesion of the renal pelvic wall |
| Serology | Elevated serum IgG4 or total IgG level | Elevated serum IgG4 or total IgG level |
| Clinical features | None | Clinical or laboratory evidence of kidney damage |
| Other organ involvement | Characteristic findings of IgG4-RD in other organs | Characteristic findings of IgG4-RD in other organs |
| Definite IgG4-TIN | The histologic feature and at least one other feature from imaging, serology or other organ involvement | The histologic feature (a and b) and at least two of other features from imaging, serology or other organ involvement |
Fig. 1The procedure of screening cases
The comparison of clinical characteristics between the high-probability IgG4-TIN group and excluded group in abundant plasma cells samples
| High-probability IgG4-TIN (n = 12) | Excluded (n = 43) | P value | |
|---|---|---|---|
| Female gender (n (%)) | 6 (50 ) | 26 (60 ) | 0.152 |
| Age (y) | 52 (30–76) | 37 (14–63) | 0.003 |
| Proteinuria (0.01-0.15 g/24 h) | 1.04 (0.21 - 2.69) | 3.12 (0.06 - 17.33) | 0.043 |
| Albumin (35–55 g/L) | 32.8 (25.7 - 42.1) | 31.8 (15–46) | 0.682 |
| Serum creatinine (44–132 μmol/L) | 311.7 (46–953) | 492.8 (105–1832) | 0.070 |
| eGFR (80-120 ml/min) | 23.6 (5.4 - 65.3) | 29.5 (3.2 - 143.1) | 0.405 |
Data are expressed as mean (minimum, maximum), number (frequency)
Clinical, radiographic, laboratory and pathological features of twelve high-probability IgG4-TIN cases
| Pt No. | Age/Gender | Clinical Diagnosis | Proteinuria (0.01-0.15g/24h) | Hematuria | ALB (35-55 g/L) | SCr (44-132μmol/L) | eGFR (80-120ml/min) | Serum IgG (751-1560mg/dL) | Serum C3 (79-152 mg/dL) | Principal Pathological Diagnosis | IgG4 (cells/HPF) | IgG4/IgG (%) | Storiform fibrosis | Stage of Fibrosis | TBM Deposits | Imaging Findings | Other Organ Involvement |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 65 M | ARF | 0.30 | - | 36 | 381 | 13.2 | 1910 | 67 | Idiopathic TIN | 14 | 23.3 | - | 0 | - | Bilateral Enlarged | - |
| 2 | 42 F | ARF, AAV | 1.41 | 4+ | 35 | 447 | 9.9 | 2370 | 78 | Pauci-immune CreGN | 22 | 56.7 | - | 0 | + | - | - |
| 3 | 52 F | SLE, CRF | 1.57 | 2+ | 30 | 273 | 15.5 | 3050 | 86 | LN | 11 | 84.6 | - | 1 | + | - | PF |
| 4 | 76 M | CGN, CRF | 1.41 | 4+ | 33 | 380 | 11.9 | 1990 | 75 | Immune complex CreGN | 10 | 43.5 | - | 1 | - | - | PF |
| 5 | 62 M | CGN, CRF | 1.17 | - | 30 | 234 | 25.6 | 4050 | 45 | Idiopathic TIN | 55 | 93.2 | + | 2 | + | Bilateral Enlarged | PF Lymph node Enlarged |
| 6 | 49 M | CGN, CRF | 0.40 | 3+ | 37.6 | 138 | 52 | 1050 | 81 | IgAN | 12 | 32.2 | - | 1 | + | - | PF |
| 7 | 33 F | ARF | 0.21 | - | 39.9 | 231 | 24.9 | 2010 | 123 | Drug-induced TIN | 22 | 58 | - | 1 | + | - | - |
| 8 | 59 M | ARF | 0.60 | 3+ | 26.6 | 1108 | 10.7 | 1380 | 86 | Anti-GBM CreGN | 29 | 60.3 | - | 1 | - | - | PF |
| 9 | 36 F | CGN, CRF | 2.69 | 3+ | 30.4 | 199 | 40.7 | 1910 | 121 | IgAN | 14 | 40.3 | - | 2 | + | - | - |
| 10 | 56 F | ARF, AAV | 1.58 | 3+ | 26.9 | 1832 | 5.4 | 2120 | 80 | Crescentic IgAN | 20 | 95 | + | 1 | + | - | PF |
| 11 | 59 M | ARF | 0.49 | - | 25.7 | 586 | 8.4 | 1860 | 106 | Immune complex CreGN | 52 | 91 | + | 2 | + | Bilateral Enlarged | - |
| 12 | 30 F | CGN,CKD2 | 0.61 | - | 42.1 | 105 | 65.3 | 1870 | 109 | IgAN | 25 | 63.7 | - | 2 | + | - | - |
CreGN, Crescentic Glomerulonephritis; AAV, antineutrophil cytoplasmic autoantibody-associated vasculitis; PF, pulmonary fibrosis; LN, lupus nephritis; IgAN, IgA nephropathy; GBM, glomerular basement membrane.
Pathological features of confirmed IgG4-TIN, high-probability IgG4-TIN and both excluded groups in abundant plasma cells samples
| Abundant plasma cells samples | High-probability IgG4-TIN | |||||
|---|---|---|---|---|---|---|
| Pathological features | High-probability IgG4-TIN (n = 12) | Excluded (n = 43) | P value 1 | Confirmed IgG4-TIN (n = 2) | Unconfirmed IgG4-TIN (n = 10) | P Value 2 |
| Inflammation infiltrating renal capsule | 4 (33.3 ) | 11 (25.6) | 0.594 | 1 (50) | 3 (30) | 0.584 |
| Inflammation infiltrating renal medulla | 6 (50) | 23 (53.5) | 0.831 | 1 (50) | 5 (50) | 1.000 |
| Isolated fibrosis | 6 (50) | 3 (7) | 0.000 | 2 (100) | 4 (40) | 0.121 |
| Collagenous fibrosis | 8 (66.7) | 7 (16.3) | 0.001 | 2 (100) | 6 (60) | 0.273 |
| Storiform fibrosis | 3 (25) | 1 (2.3) | 0.007 | 2 (100) | 1 (10) | 0.007 |
| Lymphoid follicles | 2 (16.7) | 1 (2.3) | 0.053 | 0 (0) | 2 (20) | 0.488 |
| Granulomatous lesions | 1 (8.3) | 0 (0) | 0.056 | 0 (0) | 1 (10) | 0.640 |
| Necrotizing angiitis | 1 (8.3) | 1 (2.3) | 0.326 | 0 (0) | 1 (10) | 0.640 |
| Obliterative phlebitis | 0 (0) | 0 (0) | -- | 0 (0) | 0 (0) | -- |
| Eosinophil infiltration | 8 (66.7) | 18 (41.9) | 0.128 | 2 (100) | 6 (60) | 0.273 |
| Neutrophil infiltration | 6 (50) | 14 (32.6) | 0.267 | 1 (50) | 5 (50) | 1.000 |
| Tubulitis | 9 (75) | 16 (37.2) | 0.020 | 2 (100) | 7 (70) | 0.371 |
| Peritubular capillaritis | 3 (25) | 13 (30.2) | 0.724 | 1 (50) | 2 (20) | 0.371 |
| Tubular necrosis | 8 (66.7) | 18 (41.9) | 0.128 | 0 (0) | 8 (80) | 0.091 |
| TBM immune complex deposits | 9 (75) | 12 (27.9) | 0.006 | 2 (100) | 7 (70) | 0.371 |
Data are expressed as number (frequency); P value 1: High-probability IgG4-TIN compared to Excluded; P value 2: Confirmed IgG4-TIN compared to unconfirmed; --: no statistics.
Fig. 2Histological features and immunohistochemistry findings of case twelve. a) Multi-focal fibrosis with obliteration of several tubules (×40) HE. b) Isolated glomeruli in the middle of fibrosis (×100) PAM. c) IgA deposits in mesengium (×200) IF. d) Multi-focally distributed plasma cells by CD138 test (×100) IHC. e) Focally scattered IgG4 positive cells by IgG4 test (×100) IHC. f) IgG4 test (×200) IHC
Fig. 3Pathological features of case five of histology, IHC and electron microscopy. a) Diffuse fibrosis with obliteration of most tubules and isolation of glomeruli (×40) HE. b) Typical storiform fibrosis with abundant inflammation cells (×200) PAM. c) Rich collagen fibrosis and characteristic bird’s-eye pattern (×200) Masson trichrome staining. d) Characteristic bird’s-eye pattern (×400) PAM. e) Abundant, evenly distributed, strong positive plasma cells in interstitium by CD138 test (×100) IHC. f) Abundant strong stained and evenly distributed IgG4+ plasma cells (>50 per HPF) in interstitium and tubular epithelial cells by IgG4 test (×200) IHC. g) Apparent TBM deposition of two tubules by IgG test (×200) IHC. h) Thickened TBM with scattered electron dense immune complex deposits (×4000) EM
Fig. 4A new set of criteria of IgG4-TIN for pathologist